article thumbnail

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

DAIC

HeartFlow’s Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. F.A.C.C. “The

article thumbnail

HeartFlow Announces New Reimbursement Code and Increased Payment for FFRCT

DAIC

a leader in non-invasive artificial intelligence (AI) precision coronary solutions, announced FFRCT was transitioned to a Category I Current Procedural Terminology (CPT) code beginning January 1, 2024. milla1cf Tue, 01/23/2024 - 13:44 January 23, 2024 — HeartFlow, Inc. ,

article thumbnail

Prolocor, Slingshot Bioscience Publish Paper on Prognostic Tool to Help Assess Thrombosis Risk

DAIC

"This study highlights the power of our cell mimic platform in driving next-generation tests that could enhance patient care." Clinicians need better tools to guide decision making on the choice of antiplatelet therapy in coronary artery disease patients, particularly after coronary stenting.

article thumbnail

American College of Cardiology, ACC, Releases Guide to Remote Patient Management

DAIC

In its announcement about the workbook, ACC noted that cardiologists use digital devices and wearable technology to remotely monitor their patients for a variety of chronic cardiovascular diseases, including heart failure, coronary artery disease, vascular disease and atrial fibrillation.

article thumbnail

CMS Updates Medicare Coverage for AI-Coronary Plaque Analysis

DAIC

Members of the Society of Cardiovascular Computed Tomography (SCCT) Health Policy & Practice Committee (HPPC) presented as subject matter experts during a May 2023 MAC-led Multijurisdictional Meeting on CAC Non-Invasive Technology for Coronary Artery Plaque Analysis and later provided comments on the draft LCDs that helped shape the final policies.

CMS 52
article thumbnail

Nanox Receives FDA Clearance for Upgraded Version of Advanced AI Cardiac Solution

DAIC

is the upgraded version of Nanox.AI’s cardiac solution, HealthCCSng, which has already shown tangible results in several healthcare systems, identifying patients at high risk of coronary artery disease while driving significant revenue to cardiology departments. HealthCCSng V2.0 For more information, please visit [link].

article thumbnail

American College of Cardiology Sets Full Range of Education Sessions and Meetings ACC Scientific Session, ACC.24

DAIC

Here is an overview of sessions, events and meetings coordinated to help members in particular specialties, sections and areas of interest learn and engage with peers and expert cardiology professionals to advance their practice, patient care and careers. 24 Education Sessions Symposiums at ACC The “Symposiums at ACC.24”

Education 105